Deriving Immune Modulating Drugs from Viruses—A New Class of Biologics

Deriving Immune Modulating Drugs from Viruses—A New Class of Biologics

Viruses are widely used as a platform for the production of therapeutics. Vaccines containing live, dead and components of viruses, gene therapy vectors and oncolytic viruses are key examples of clinically-approved therapeutic uses for viruses. Despite this, the use of virus-derived proteins as natu...

Full description

Bibliographic Details
Main Authors: Jordan R. Yaron, Liqiang Zhang, Qiuyun Guo, Michelle Burgin, Lauren N. Schutz, Enkidia Awo, Lyn Wise, Kurt L. Krause, Cristhian J. Ildefonso, Jacek M. Kwiecien, Michael Juby, Masmudur M. Rahman, Hao Chen, Richard W. Moyer, Antonio Alcami, Grant McFadden, Alexandra R. Lucas
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
virus
immune modulation
protein
serpin
chemokine binding protein
chemokine
Online Access:https://www.mdpi.com/2077-0383/9/4/972

Internet

https://www.mdpi.com/2077-0383/9/4/972

Similar Items